7.40. Analysis.
Comparison 7 Heterogeneity analyses, Outcome 40 Fasting plasma glucose‐ total‐ number of basal doses (intermediate acting).
Comparison 7 Heterogeneity analyses, Outcome 40 Fasting plasma glucose‐ total‐ number of basal doses (intermediate acting).